Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Chem Biodivers ; 21(6): e202400507, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38606561

ABSTRACT

Three new C10 and C12 aliphatic δ-lactones (1-3), three new fatty acid methyl esters (4-6), and eight known compounds (7-14) were isolated from the marine Aureobasidium sp. LUO5. Their structures were established by detailed analyses of the NMR, HRESIMS, optical rotation, and ECD data. All isolates were tested for their inhibitory effects on nitric oxide production in LPS-induced BV-2 cells. Notably, compound 4 displayed the strongest inhibitory effect with the IC50 value of 120.3 nM.


Subject(s)
Aureobasidium , Nitric Oxide , Animals , Mice , Aureobasidium/chemistry , Aureobasidium/metabolism , Cell Line , Lipopolysaccharides/antagonists & inhibitors , Lipopolysaccharides/pharmacology , Molecular Conformation , Molecular Structure , Nitric Oxide/antagonists & inhibitors , Nitric Oxide/biosynthesis , Nitric Oxide/metabolism , Lactones
2.
Mar Drugs ; 21(10)2023 Oct 14.
Article in English | MEDLINE | ID: mdl-37888473

ABSTRACT

Three new polyketides (penidihydrocitrinins A-C, 1-3) and fourteen known compounds (4-17) were isolated from the deep-sea-derived Penicillium citrinum W17. Their structures were elucidated by comprehensive analyses of 1D and 2D NMR, HRESIMS, and ECD calculations. Compounds 1-17 were evaluated for their anti-inflammatory and anti-osteoporotic bioactivities. All isolates exhibited significant inhibitory effects on LPS-stimulated nitric oxide production in murine brain microglial BV-2 cells in a dose-response manner. Notably, compound 14 displayed the strongest effect with the IC50 value of 4.7 µM. Additionally, compounds 6, 7, and 8 significantly enhanced osteoblast mineralization, which was comparable to that of the positive control, purmorphamine. Furthermore, these three compounds also suppressed osteoclastogenesis in a dose-dependent manner under the concentrations of 2.5 µM, 5.0 µM, and 10 µM.


Subject(s)
Penicillium , Polyketides , Animals , Mice , Polyketides/pharmacology , Polyketides/chemistry , Molecular Structure , Penicillium/chemistry , Anti-Inflammatory Agents/pharmacology
3.
Mar Drugs ; 21(11)2023 Nov 16.
Article in English | MEDLINE | ID: mdl-37999419

ABSTRACT

A systematic investigation combined with a Global Natural Products Social (GNPS) molecular networking approach, was conducted on the metabolites of the deep-sea-derived fungus Samsoniella hepiali W7, leading to the isolation of three new fusaric acid derivatives, hepialiamides A-C (1-3) and one novel hybrid polyketide hepialide (4), together with 18 known miscellaneous compounds (5-22). The structures of the new compounds were elucidated through detailed spectroscopic analysis. as well as TD-DFT-based ECD calculation. All isolates were tested for anti-inflammatory activity in vitro. Under a concentration of 1 µM, compounds 8, 11, 13, 21, and 22 showed potent inhibitory activity against nitric oxide production in lipopolysaccharide (LPS)-activated BV-2 microglia cells, with inhibition rates of 34.2%, 30.7%, 32.9%, 38.6%, and 58.2%, respectively. Of particularly note is compound 22, which exhibited the most remarkable inhibitory activity, with an IC50 value of 426.2 nM.


Subject(s)
Fusaric Acid , Paecilomyces , Fusaric Acid/pharmacology , Macrophages , Anti-Inflammatory Agents , Molecular Structure
4.
J Nat Prod ; 82(8): 2307-2331, 2019 08 23.
Article in English | MEDLINE | ID: mdl-31403790

ABSTRACT

Aphidicolin, a potent DNA polymerase α inhibitor, has been explored in clinical trials for the treatment of cancer. So far, about 300 modified aphidicolins have been discovered. However, none have shown a stronger effect. Herein, we report 71 new (aphidicolins A1-A71, 1-71) and eight known (72-79) aphidicolin congeners from Botryotinia fuckeliana MCCC 3A00494, a fungus isolated from the western Pacific Ocean (-5572 m). The structures of 1-71 were determined through extensive spectroscopic analysis, X-ray crystallography, chemical derivatization, modified Mosher's method, and the ECD exciton chirality method. Compounds 54-57 and 58-64 are novel 6/6/5/6/5 pentacyclic aphidicolins featuring tetrahydrofuran and dihydrofuran rings, respectively, while compounds 65-71 are rare noraphidicolins. Aphidicolin A8 (8) significantly induced apoptosis in T24 (IC50 = 2.5 µM) and HL-60 (IC50 = 6.1 µM) cancer cells by causing DNA damage. By docking its structure to the human DNA polymerase α binding pocket, 8 was found to form tight intermolecular contacts, elaborating aphidicolin A8 as a potently cytotoxic lead compound.


Subject(s)
Aphidicolin/chemistry , Botrytis/chemistry , Marine Biology , Carbon-13 Magnetic Resonance Spectroscopy , Crystallography, X-Ray , Molecular Structure , Proton Magnetic Resonance Spectroscopy , Spectrometry, Mass, Electrospray Ionization
5.
Mar Drugs ; 16(11)2018 Nov 02.
Article in English | MEDLINE | ID: mdl-30400195

ABSTRACT

To investigate structurally novel and anti-neuroinflammatory natural compounds from marine-derived microorganisms, the secondary metabolites of Aspergillus terreus Y10, a fungus separated from the sediment of the coast in the South China Sea, were studied. Three new compounds (2⁻4), with novel open-ring butenolide skeletons, were isolated from the ethyl acetate extract of the culture medium. In addition, a typical new butenolide, asperteretal F (1), was found to dose-dependently inhibit tumor necrosis factor (TNF-α) generation with an IC50 of 7.6 µg/mL. The present study shows the existence of open-ring butenolides, and suggests that butenolides such as asperteretal F (1) are a promising new anti-neuroinflammatroy candidate for neurodegenerative diseases.


Subject(s)
4-Butyrolactone/analogs & derivatives , Aquatic Organisms/metabolism , Aspergillus/metabolism , Biological Products/pharmacology , Tumor Necrosis Factor-alpha/antagonists & inhibitors , 4-Butyrolactone/chemistry , 4-Butyrolactone/isolation & purification , 4-Butyrolactone/pharmacology , 4-Butyrolactone/therapeutic use , Animals , Anti-Inflammatory Agents/chemistry , Anti-Inflammatory Agents/isolation & purification , Anti-Inflammatory Agents/pharmacology , Anti-Inflammatory Agents/therapeutic use , Biological Products/chemistry , Biological Products/isolation & purification , Biological Products/therapeutic use , Cell Line , Humans , Inhibitory Concentration 50 , Lipopolysaccharides/immunology , Mice , Microglia/drug effects , Microglia/immunology , Molecular Structure , Neurodegenerative Diseases/drug therapy , Neurodegenerative Diseases/immunology , Neuroprotective Agents/chemistry , Neuroprotective Agents/isolation & purification , Neuroprotective Agents/pharmacology , Neuroprotective Agents/therapeutic use , Tumor Necrosis Factor-alpha/immunology
6.
Eur J Med Chem ; 46(11): 5480-6, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21955681

ABSTRACT

An improved four-step approach for the stereoselective synthesis of long-chain anti-2-amino-3-alkanols is described. Using this method, the syntheses of antiproliferative (antitumoral) compounds, spisulosine (ES-285, 2), clavaminols A and B (3 and 4), the deacetylated products of clavaminols H and N (7 and 8), as well as (2S,3R)-2-aminododecan-3-ol (9) and xestoaminol C (10), have been achieved in excellent diastereoselectivities. In vitro study showed that these compounds induced cell death and dose-dependently inhibited cell proliferation in human glioblastoma cell line SHG-44, indicating the anti-tumor property of this series of compounds.


Subject(s)
Alcohols/chemical synthesis , Alcohols/pharmacology , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/pharmacology , Chemistry Techniques, Synthetic , Alcohols/chemistry , Alcohols/toxicity , Antineoplastic Agents/chemistry , Antineoplastic Agents/toxicity , Cell Line, Tumor , Cell Proliferation/drug effects , Dose-Response Relationship, Drug , Humans , Stereoisomerism , Substrate Specificity
SELECTION OF CITATIONS
SEARCH DETAIL